Amgen plans to open new technology, innovation site in Hyderabad
Thousand Oaks: Amgen has announced plans to open a new technology and innovation site in Hyderabad, India. The site, known as Amgen India, will accelerate digital capabilities across the global organization to further advance Amgen's pipeline of medicines.
Amgen India will be located in HITEC City, a suburb of Hyderabad, occupying six floors of the RMZ Spire Tower 110. The site can accommodate up to 3,000 people and will be operational in Q4 2024.
"At a time when a quickly aging global population needs more innovation, the convergence of biotechnology and technology is enabling Amgen to work with greater speed, confidence, and efficiency — an incredibly exciting milestone for which we have been preparing for over a decade," said David M. Reese, M.D., executive vice president and chief technology officer at Amgen. "Amgen has been a leader in biotechnology for over 40 years and establishing this new site in India, a country known for its world-class technology and life sciences talent, marks a significant step forward in our journey to deliver on our mission to serve patients."
"Amgen India will initially build and accelerate new technology solutions and digital capabilities at scale that will enhance efficiencies across the enterprise. The site will offer roles that strengthen key areas of Amgen's business, including AI, data science, life science and other additional global capabilities over time," the Company stated.
For Amgen's expanded presence in India, Som Chattopadhyay has been appointed national executive for India.
"Amgen's new site in Hyderabad underscores the city's position as a hub for innovation and technology," said Chief Minister Sri Anumula Revanth Reddy. "We are proud to welcome a global trailblazer of the biotechnology industry. Amgen's unwavering mission to serve patients will be incredibly inspiring for the world-class technology talent seeking to make a meaningful impact on people around the world."
Amgen has nearly 27,000 employees and has a presence in approximately 100 countries and regions worldwide, including India.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.